重组人骨形态发生蛋白-2质粒转染诱导人脐血间充质干细胞软骨分化研究

doi:10.3877/cma.j.issn.2096-0263.2019.02.003

目的

探究从人脐血中提取间充质干细胞，重组质粒pIRES2-EGFP-hBMP-2转染干细胞并诱导其成软骨化的可能性。

方法

采用密度梯度离心方法获取脐带血中细胞，依据贴壁时间不同获得间充质干细胞，流式细胞仪检测表面抗原表达鉴定细胞；然后把重组有pIRES2-EGFP-hBMP-2的质粒导入间充质干细胞，观察EGFP的表达；ELISA方法检测在不同时间收集的培养基上清中hBMP-2蛋白含量，采用免疫荧光和RT-PCR方法检测目的蛋白和基因表达。转染成功后继续培养细胞2 w，免疫组化检测细胞Ⅱ型胶原的表达和RT-PCR检测软骨特异性标志物软骨连接蛋白（CRLT1）的表达。

结果

两种方法可以获取人脐血间充质干细胞，流式细胞术鉴定发现CD90、CD105、CD146高表达，CD34、CD45、Anti-HLA-DR不表达。非脂质载体包裹重组质粒pIRES2-EGFP-hBMP-2可成功导入脐血间充质干细胞，转染率为（27.7±7.6）%。ELISA检测实验组和对照组hBMP-2的表达结果有统计学差异（t=3.355，P<0.01）。RT-PCR结果表明hBMP-2基因稳定转录，免疫荧光标记hBMP-2蛋白呈红色荧光。Ⅱ型胶原免疫组化染色示部分细胞被染成棕黄色，RT-PCR结果表明加入转染后的干细胞组CRLT1的表达量比未转染的干细胞组高（t=59.700，P<0.05）。

结论

重组hBMP-2基因可以成功转染人脐血间充质干细胞并在胞内稳定表达，且有hBMP-2分泌，并可促进其表达Ⅱ型胶原蛋白及软骨连接蛋白，可向软骨细胞化诱导。

关键词: 重组人骨形态发生蛋白-2, 间充质干细胞, 基因编辑, 脂质体

Objective

To gain mesenchymal stem cells from humanumbilical cord blood and transfect the recombinant plasmid pIRES2-EGFP-hBMP-2 into human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) with liposome and to induce hUCB-MSCs osteoblastization.

Methods

Separated cells from human umbilical cord blood with density gradient centrifugation, and hUCB-MSCs were gained with adherent method, using flow cytometry to identify the surface markers of hUCB-MSCs. Transfected recombinate plasmid pIRES2-EGFP-hBMP-2 into the third generation hUCB-MSCs with X-treme GENE HP DNA Transfection reagent, then detected the intensity of EGFP. Collected the medium at different time after transfection and the hBMP-2 content in the medium was measured by ELISA. Use immunofluorescent to locate the existence of hBMP-2 within the cells and RT-PCR techniques to measure the transcription of the hBMP-2 gene. Two weeks after transfection, immunohistochemistry were used to detect the type Ⅱ collagen for discovering the possible changes of hUCB-MSCs.

Results

HUCB-MSCs could be isolated from blood in umbilical cord by density gradient centrifugation and the different ability of adherence. Flow cytometry showed that the hUCB-MSCs positively expressed CD90, CD105 and CD146, and did not express CD34, CD45 and Anti-HLA-DR. The recombinant plasmid pIRES2-EGFP-hBMP-2 was successfully fused into umbilical cord blood mesenchymal stem cells, and the fusion rate was (27.7±7.6)%. The ELISA test compared the expression of hBMP-2 between the experimental group and the control group, P<0.01 showed a statistically significant difference. RT-PCR results showed that the hBMP-2 gene was stably transcribed and the immunofluorescently labeled hBMP-2 protein showed red fluorescence. Immunohistochemical staining of type Ⅱ collagen showed that some cells were browned. RT-PCR results showed that the expression of CRLT1 in umbilical cord blood mesenchymal stem cells transfected with BMP-2 was higher than that in untransfected umbilical cord blood mesenchymal stem cells and human synovial fibrosis group (P<0.05).

Conclusions

Recombinat plasmid pIRES2-EGFP-BMP-2 coated with X-treme CENE can be successfully transfected into hUCB-MSCs. Both the marker gene and objectivegene can be transcribed and expressed in hUCB-MSCs, and cells can synthesis hBMP-2, which stimulates the hUCB-MSCs'differentiation towards to chondrocytes.

Key words: Recombinant human bone morphogenetic protein-2, Mesenchymal stem cells, Gene editing, Liposomes

图1 细胞贴壁7 d后，生长状态良好，呈长梭状（100X）

图2 流式细胞仪鉴定：CD34（0.13%），CD45（0.14%），CD90（99.88%），CD105（99.95%），CD146（73.91%），Anti-HLA-DR（1.57%）

图3~5 荧光显微镜下绿荧光蛋白（EGFP）的表达（200X）。图3 换液后EGFP表达情况，亮度较强；图4 48 h EGFP表达达到最大数目；图5 72 hEGFP强度降低

图11 ELISA检验结果，转染组BMP-2含量明显高于未转染组，转染组在转染后BMP-2蛋白量持续增高，峰值出现在转染后48 h，为3 006 pg/ml，其后开始下降，但仍高于对照组其他时段

表1 加入重组基因后不同时间点对照组与实验组hBMP-2蛋白浓度（pg/ml，±s）

组别	12 h	24 h	36 h	48 h	60 h	72 h	84 h	96 h
对照组	128.5±1.9	212.4±2.1	321.6±2.0	448.5±3.1	400.1±2.9	384.3±1.4	375.8±1.4	366.2±3.0
实验组	787.1±1.2	1215.7±4.9	1948.3±1.6	3006.0±4.6	2664.9±7.6	2367.3±8.4	2196.0±4.6	1995.3±5.2
t值	662.562	418.266	1429.045	1027.186	622.344	522.479	849.123	609.180
P值	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

表1 加入重组基因后不同时间点对照组与实验组hBMP-2蛋白浓度（pg/ml，±s）

组别	12 h	24 h	36 h	48 h	60 h	72 h	84 h	96 h
对照组	128.5±1.9	212.4±2.1	321.6±2.0	448.5±3.1	400.1±2.9	384.3±1.4	375.8±1.4	366.2±3.0
实验组	787.1±1.2	1215.7±4.9	1948.3±1.6	3006.0±4.6	2664.9±7.6	2367.3±8.4	2196.0±4.6	1995.3±5.2
t值	662.562	418.266	1429.045	1027.186	622.344	522.479	849.123	609.180
P值	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

1	Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [J]. Arthritis Rheum, 2001, 44(6):1237-1247.
2	胥少汀，葛宝丰，徐印坎,等.实用骨科学[M].北京:人民军医出版社, 2015: 1671-1677.
3	Bhardwaj N, Devi D, Mandal BB. Tissue-Engineered cartilage: the crossroads of biomaterials, cells and stimulating factors [J]. Macromol Biosci, 2015, 15(2):153-182.
4	Yamasaki S, Mera H, Itokazu M, et al. Cartilage repair with autologous bone marrow mesenchymal stem cell transplantation: review of preclinical and clinical studies [J]. Cartilage, 2014, 5(4):196-202.
5	Odabas S, Elçin AE, Elçin YM. Isolation and characterization of mesenchymal stem cells [J]. Methods Mol Biol, 2014, 1109:47-63.
6	Hassan G, Kasem I, Soukkarieh C, et al. A simple method to isolate and expand human umbilical cord derived mesenchymal stem cells: using explant method and umbilical cord blood serum [J]. Int J Stem Cells, 2017, 10(2):184-192.
7	Dufrane D. Impact of age on human adipose stem cells for bone tissue engineering [J]. Cell Transplant, 2017, 26(9, SI):1496-1504.
8	Singh J, Mann A, Kumar D, et al. Cultured Buffalo umbilical cord matrix cells exhibit characteristics of multipotent mesenchymal stem cells [J]. In Vitro Cell Dev Biol Anim, 2013, 49(6):408-416.
9	Jaing TH. Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine [J]. Cell Transplant, 2014, 23(4/5):493-496.
10	Kim JS, Lee HK, Kim MR, et al. Differentially expressed proteins of mesenchymal stem cells derived from human cord blood (hUCB) during osteogenic differentiation [J]. Biosci Biotechnol Biochem, 2008, 72(9):2309-2317.
11	Erices A, Conget P, Mingudl JJ, et al. Meaenchymaal progenitor cells in human umbilical cord blood [J]. Br J Heamatol, 2000, 109(1):235-242.
12	Cardenas C, Kwon JY, Maeng YS. Human cord Blood-Derived CD133+/C-Kit(+)/Lin(-) cells have bipotential ability to differentiate into mesenchymal stem cells and outgrowth endothelial cells [J]. Stem Cells Int, 2016:7162160.
13	Hua J, Gong J, Meng HB, et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: Proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow [J]. Cell Biol Int, 2014, 38(2):198-210.
14	Lee DH, Ahn Y, Kim SU, et al. Targeting rat brainstem glioma using human neural stem cells and human messenchymal stem cells [J]. Clin Cancer Res, 2009, 15(15):4925-4934
15	Jin HJ, Park SK, Oh W, et al. Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells [J]. Biochem Biophys Res Commun, 2009, 381(4):676-681.
16	Mohyeddin Bonab MA, Alimoghaddam KA, Goliaei ZA, et al. Which factors can affect cord blood variables [J]. Transfusion, 2004, 44(5):690-693.
17	Romanov YA, Svintsitskaya VA, Smimov VN. Searching for alternative sources of postnatal human mesenehymal stem cells: candidate MSC-like cells from umbilical cord [J]. Stem Cells, 2003, 21(1):105-110.
18	黄宏宇，刘国平，段莉,等.人脐血间充质干细胞培养方法的比较[J].中国组织工程研究, 2014, 18(37):5961-5966.
19	Feldmann RE, Bieback K, Maurer MH, et al. Stem cell proteomes: A profile of human mesenchymal stem cells derived from umbilical cord blood [J]. Electrophoresis, 2005, 26(14):2749-2758.
20	郑德宇，刘建生，杨依勇,等.成骨诱导后的脐血间充质干细胞与β-磷酸三钙复合植骨材料对兔颅骨缺损的修复作用[J].西安交通大学学报:医学版, 2011, 32(4):441-444, 476.
21	Wang FS, Yang KD, Wang CJ, et al. Shockwave stimualates Oxygen radical-mediated osteogenesis of the mesenehymal cells from human umbilical cord blood [J]. J Bone Miner Res, 2004, 19(6):973-982.
22	杨依勇，朱慧敏，秦书俭,等.脐带血间充质干细胞的成骨诱导及结果检测[J].解剖学杂志, 2010, 33(5):692-694.
23	Gomez-Leduc T, Hervieu M, Legendre FA, et al. Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering [J]. Sci Rep, 2016, 8(6):32786.
24	Li H, Nie B, Du Z, et al. Bacitracin promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by stimulating the bone morphogenetic protein-2/Smad axis [J]. Biomed Pharmacother, 2018, 103:588-597.
25	Bougioukli S, Sugiyama O, Pannell W, et al. Gene therapy for bone repair using human cells: superior osteogenic potential of bone morphogenetic protein 2-Transduced mesenchymal stem cells derived from adipose tissue compared to bone marrow [J]. Hum Gene Ther, 2018, 29(4):507-519.
26	Nasrabadi D, Rezaeiani S, Eslaminejad MB, et al. Improved protocol for chondrogenic differentiation of bone marrow derived mesenchymal stem cells-Effect of PTHrP and FGF-2 on TGF beta 1/BMP2-Induced chondrocytes hypertrophy [J]. Stem Cell Rev, 2018, 14(5):755-766.
27	徐建民，王兆朋，王恒孝.骨形态发生蛋白-2在兔骨折愈合过程中的作用[J].中国矫形外科杂志, 2016, 24(10):920-925.
28	Deshmukh SN, Dive AM, Moharil R, et al. Enigmatic insight into collagen [J]. J Oral Maxillofac Pathol, 2016, 20(2):276-283.
29	Lindenmair A, Nürnberger S, Stadler G, et.al. Intact human amniotic membrane differentiated towards the chondrogenic lineage [J]. Cell Tissue Bank, 2014, 15(2):213-225.

[1]	沈纵, 魏晨如, 朱邦晖, 包郁露, 伍国胜, 孙瑜. 间充质干细胞治疗吸入性损伤的动物实验研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 180-183.
[2]	唐英俊, 李华娟, 王赛妮, 徐旺, 刘峰, 李羲, 郝新宝, 黄华萍. 人脐带间充质干细胞治疗COPD小鼠及机制分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 476-480.
[3]	李埝, 赵建军, 张建勇, 赵睿桢. hAMSCs调控MAPK信号通路对急性肺损伤AQP1的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 156-163.
[4]	王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[5]	刘文慧, 吴涛, 张曦. 间充质干细胞联合血小板生成素受体激动剂在异基因造血干细胞移植后血小板恢复中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 242-246.
[6]	龙慧玲, 林蜜, 邵婷. 三维球体间充质干细胞培养技术的研究进展及其应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 229-234.
[7]	李晔, 何洁, 胡锦秀, 王金祥, 田川, 潘杭, 陈梦蝶, 赵晓娟, 叶丽, 张敏, 潘兴华. 高活性间充质干细胞干预猕猴卵巢衰老的研究[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 210-219.
[8]	袁久莉, 刘丹, 李林藜, 刘晋宇. 毛囊间充质干细胞的基础研究及临床应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 189-192.
[9]	秦富豪, 郑正, 江滨. 间充质干细胞在克罗恩病肛瘘治疗中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 172-177.
[10]	陈玉婷, 周影, 陆雅斐, 江滨. 缺氧预处理间充质干细胞的功能及机制研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 115-120.
[11]	冯星, 靳洪涛, 马隽, 宋永周, 刘爱京. 间充质干细胞治疗炎性关节炎的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 87-92.
[12]	宋艳琪, 任雪景, 王文娟, 韩秋霞, 续玥, 庄凯婷, 肖拓, 蔡广研. 间充质干细胞对顺铂诱导的小鼠急性肾损伤中细胞铁死亡的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 187-193.
[13]	杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[14]	陈客宏. 干细胞外泌体防治腹膜透析腹膜纤维化新技术研究[J]. 中华肾病研究电子杂志, 2023, 12(03): 180-180.
[15]	梁宇同, 丁旭, 马国慧, 黄艳红. 间充质干细胞在宫腔粘连治疗中的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 596-599.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Research on human umbilical cord bloodmesenchymal stem cells transfected with the gene of human bone morphogenetic protein-2

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Research on human umbilical cord bloodmesenchymal stem cells transfected with the gene of human bone morphogenetic protein-2